Growth and change in the CUA literature CEVR researchers published a new paper in Value in Health: “The Changing Face of the Cost-Utility Literature."
New paper by CEVR researchers in Value in Health: “Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence."
New paper by CEVR researchers in the American Journal of Managed Care: “Multiple Chronic Conditions in Type 2 Diabetes Mellitus: Prevalence and Consequences."
Special report from CEVR researchers in Expert Review of Pharmacoeconomics and Outcomes Research: "The lag from FDA approval to published cost-utility evidence."
New paper by CEVR researchers in the journal Blood: “Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses.”